# Development of Cognitive Assessment Tools in Parkinson Disease

> **NCT00556764** · EARLY_PHASE1 · COMPLETED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 75 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** [123I] IBVM and SPECT imaging
- **DRUG:** Subjects will undergo the 123-I IBVM imaging visit

## Key facts

- **NCT ID:** NCT00556764
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2012-02-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556764, "Development of Cognitive Assessment Tools in Parkinson Disease". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00556764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*